NIH-funded research R01 grant

Exploring how depression affects brain health and cognitive decline in older adults with mild cognitive impairment.

Official title: Clarifying the association of depressive symptoms with cortico-limbic tau, cerebral blood flow, neurodegeneration, and longitudinal cognitive decline in individuals with mild cognitive impairment

Funded at University of California, San Francisco · NIH-11054506 · Data updated 2026-11-12

This study is looking at how depression might affect brain health in older adults with mild cognitive impairment, helping us understand if and how it could speed up memory problems and possibly lead to dementia.

More Mild Cognitive Impairment research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startApril 15, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$1,711,908
NIH project number1R01AG091718-01
Project IDNIH-11054506 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults with mild cognitive impairment who also experience symptoms of depression.

Less likely to help

Patients without mild cognitive impairment or significant depressive symptoms may not benefit from this research.

What this research studies

This research investigates the connection between depressive symptoms and brain changes in older adults who have mild cognitive impairment. It focuses on how tau protein accumulation, cerebral blood flow, and neurodegeneration relate to cognitive decline and depression. By examining these factors, the study aims to clarify the role of depression in accelerating cognitive decline and its potential links to dementia. Participants will undergo assessments to measure their depressive symptoms and brain health over time.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for depression in older adults, potentially slowing cognitive decline and reducing dementia risk.

How similar studies have gone: Previous research has shown promising results in understanding the relationship between depression and cognitive decline, but this specific approach focusing on tau protein and cerebral blood flow is relatively novel.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Mackin, Robert Scott — University of California, San Francisco
  • Study coordinator: Mackin, Robert Scott

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.